This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.
Eligibility
Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients aged 18-60 years.
* Both sexes.
* Presence of reticular veins and/or telangiectasias (CEAP classification C1).
* Fitzpatrick skin types II-V.
* Patients seeking cosmetic treatment.
Exclusion Criteria:
* Pregnancy or lactation.
* History of deep vein thrombosis.
* Coagulation disorders.
* Allergy to sclerosant agents.
* Active skin infection at treatment site.
* Previous treatment of target veins within 6 months.
* Great saphenous vein or short saphenous vein incompetence.
* Deep venous insufficiency or thrombosis.
* Abnormal venous duplex findings.
Primary outcome measure(s)
Degree of vein clearance — 6 months postoperatively Degree of vein clearance will be assessed by immediate endpoint response during laser application, defined as either instantaneous disappearance of the vein or an immediate change in vein color.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.